MediciNova
MNOV
48 hedge funds and large institutions have $35.8M invested in MediciNova in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 21.88% → 21.87% (-0.01%)
6% less funds holding
Funds holding: 51 → 48 (-3)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
45% less capital invested
Capital invested by funds: $64.6M → $35.8M (-$28.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.08M |
| 2 |
Morgan Stanley
New York
|
+$888K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$341K |
| 4 |
Two Sigma Investments
New York
|
+$175K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$1.02M |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$417K |
| 3 |
Millennium Management
New York
|
-$319K |
| 4 |
Squarepoint
New York
|
-$279K |
| 5 |
Barclays
London,
United Kingdom
|
-$147K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
51
HRT Financial
New York
| – | -$126K | -18,700 | Closed |
|
|
MIM
52
MetLife Investment Management
Whippany,
New Jersey
| – | -$126K | -18,638 | Closed |
|
|
AGM
53
Alpine Global Management
New York
| – | -$98K | -14,467 | Closed |
|
|
PP
54
Paloma Partners
Greenwich,
Connecticut
| – | -$82K | -12,100 | Closed |
|
|
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$74.3K | -11,026 | Closed |
|
|
CSS
56
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$73K | -10,800 | Closed |
|
57
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$36K | -5,360 | Closed |
|
MNOV Hedge Fund Activity: Q1 2020 in Review
48 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2020, worth a combined $35.8M — down 45% from $64.6M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of MNOV and 7 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 13 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.08M. The largest seller was D.E. Shaw & Co, cutting an estimated $1.02M.
- 48 institutional investors held MediciNova (MNOV) as of Q1 2020, down from 51 in Q4 2019.
- Funds reported $35.8M of MediciNova stock for Q1 2020, down 45% quarter-over-quarter.
- 7 funds opened new MediciNova positions in Q1 2020 and 10 closed out, a net change of -3 holders.
- The largest MediciNova buyer in Q1 2020 was Renaissance Technologies, an estimated $1.08M added.
- The largest MediciNova seller in Q1 2020 was D.E. Shaw & Co, an estimated $1.02M sold.
Based on aggregated 13F filings for Q1 2020.